The latest news:

• Exclusive: Germany OKs Northwest Bio brain cancer drug, shares soar         Great news!  DC-Vax can now be sold in Germany.  I do not know yet if Americans can go get it and bring it back. If anyone tries, please let me know how it goes.
  



• Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma.          It is too early to tell if it would help people with gbms, but the best thing is that the drugs are already approved, so if the trial looks good,  we can use these off label  quickly!
  



• Implications of bevacizumab (Avastin) discontinuation in adults with recurrent glioblastoma.         This article looked at GBM patients  who took Avastin for longer than 6 months and then discontinued it.  1/4 of the patients stopped for reasons other than tumor progression, and 3/4 stopped because of tumor progression. Then they analysed what happened, looking for a "theoretical" rebound effect. They didn't find it. Those who stopped because of other reasons did a lot better than those who stopped because of progression.
  

BrainTumor Co-Payment Assistance Program Status:

• Almost closed to new applicants - Call first